<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
< Back to all Breaking News
EXEL
12/8/2022 08:12am
Exelixis reports initial results from dose-escalation stage of QUARTZ-101 study

dynamic_feed Breaking News